2004 CTI Annual Report
Together we are redefining the landscape of cancer therapies. cti annual report 2004 Cell Therapeutics, Inc. 501 Elliott Avenue West Seattle, Washington 98119 206.282.7100 www.cticseattle.com directors* senior management team* James A. Bianco, M.D. James A. Bianco, M.D. President, Chief Executive OKicer, and Director President, Chief Executive Ogcer, and Director Cell Therapeutics, Inc. Steve Aselage Max E. Link, Ph.D.(1, 2) Executive Vice President, Chairman of the Board of Directors Global Commercial Operations Former Chairman and CEO, Centerpulse, Ltd. Louis A. Bianco John M. Fluke Jr.(2, 3) Executive Vice President, Director Finance and Administration Chairman, Fluke Capital Management James Canfield, S.P.H.R.** Vartan Gregorian, Ph.D.(1) Executive Vice President, Director Chief Administrative Ogcer President, Carnegie Corporation Richard E. Leigh, Jr. Mary O. Mundinger, D.P.H.(1, 3) Executive Vice President, Director General Counsel and Corporate Secretary Dean of School of Nursing, Columbia University Jack W. Singer, M.D. Phillip M. Nudelman, Ph.D.(2, 3) Executive Vice President, Director Chief Medical Ogcer, and Director President and CEO, Hope Heart Institute Silvano Spinelli Erich Platzer, M.D. Executive Vice President, Director Development and Managing Director, Former Chairman of the Board of Directors Cell Therapeutics (Europe) S.r.l., and Director Novuspharma Except for the historical information contained herein, the matters Jack W. Singer, M.D. set forth in this Annual Report include information concerning Director our drug development pipeline, including anticipated regulatory timelines and the status of clinical trials, which are forward-looking Executive Vice President, Chief Medical Ogcer statements within the meaning of the “safe harbor” provisions of Cell Therapeutics, Inc.
[Show full text]